Abstract | OBJECTIVE: STUDY DESIGN: A decision analytic model was built to compare treating vs not treating mild GDM. The primary outcome was the incremental cost per quality-adjusted life year (QALY). All probabilities, costs, and benefits were derived from the literature. Base case, sensitivity analyses, and a Monte Carlo simulation were performed. RESULTS: Treating mild GDM was more expensive, more effective, and cost-effective at $20,412 per QALY. Treatment remained cost-effective when the incremental cost to treat GDM was less than $3555 or if treatment met at least 49% of its reported efficacy at the baseline cost to treat of $1786. CONCLUSION:
|
Authors | Mika S Ohno, Teresa N Sparks, Yvonne W Cheng, Aaron B Caughey |
Journal | American journal of obstetrics and gynecology
(Am J Obstet Gynecol)
Vol. 205
Issue 3
Pg. 282.e1-7
(Sep 2011)
ISSN: 1097-6868 [Electronic] United States |
PMID | 22071065
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Copyright | Copyright © 2011 Mosby, Inc. All rights reserved. |
Topics |
- Adult
- Cesarean Section
(economics)
- Cost-Benefit Analysis
- Decision Support Techniques
- Diabetes, Gestational
(drug therapy, economics)
- Dystocia
(economics)
- Female
- Health Care Costs
- Humans
- Pregnancy
- Quality-Adjusted Life Years
- Severity of Illness Index
|